RenovoRx (RNXT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.14, -4.20% vs the prior close of $1.19.
- Volume 271.83K shares, 0.3x its 50-day average (light).
- New SEC filings: RW (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
RNXT slides 4.2% to $1.14. Closed at $1.14, -4.20% vs the prior close of $1.19. Day range $1.14–$1.22, opened at $1.21.
RNXT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RNXT slides 4.2% to $1.14
- Closed at $1.14, -4.20% vs the prior close of $1.19. Day range $1.14–$1.22, opened at $1.21.
- Volume was 271.83K shares, 0.3x its 50-day average of 949.10K — lighter than usual.
- Price is -26.1% vs its 50-day average ($1.54) and +4.8% vs its 200-day average ($1.09).
- 52-week range $0.70–$2.59; today's close sits at 23% of that range, 56.0% below the 52-week high.
Oct 15, 2026 — RNXT jumps 6.3% to $1.19
- Closed at $1.19, +6.25% vs the prior close of $1.12. Day range $1.11–$1.22, opened at $1.11.
- Volume was 328.60K shares, 0.3x its 50-day average of 948.86K — lighter than usual.
- Price is -22.8% vs its 50-day average ($1.54) and +9.5% vs its 200-day average ($1.09).
- 52-week range $0.70–$2.59; today's close sits at 26% of that range, 54.1% below the 52-week high.
Oct 14, 2026 — RNXT dips 2.6% to $1.12, a 1-month low, 8 down days in a row
- Closed at $1.12, -2.61% vs the prior close of $1.15. Day range $1.09–$1.15, opened at $1.13.
- Volume was 624.40K shares, 0.7x its 50-day average of 944.41K.
- Price is -27.3% vs its 50-day average ($1.54) and +3.3% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 22% of that range, 56.8% below the 52-week high.
- That makes 8 straight losses.
Oct 13, 2026 — RNXT slides 8.0% to $1.15, a 1-month low, 7 down days in a row
- Closed at $1.15, -8.00% vs the prior close of $1.25. Day range $1.13–$1.27, opened at $1.24.
- Volume was 942.40K shares, 1.0x its 50-day average of 939.63K.
- Price is -25.2% vs its 50-day average ($1.54) and +6.2% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 24% of that range, 55.6% below the 52-week high.
- That makes 7 straight losses.
Oct 12, 2026 — RNXT dips 2.3% to $1.25, a 1-month low, 6 down days in a row
- Closed at $1.25, -2.34% vs the prior close of $1.28. Day range $1.25–$1.32, opened at $1.26.
- Volume was 254.10K shares, 0.3x its 50-day average of 939.45K — lighter than usual.
- Price is -18.6% vs its 50-day average ($1.54) and +15.5% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 29% of that range, 51.7% below the 52-week high.
- That makes 6 straight losses.
Oct 9, 2026 — RNXT slides 3.8% to $1.28, a 1-month low, 5 down days in a row
- Closed at $1.28, -3.76% vs the prior close of $1.33. Day range $1.25–$1.35, opened at $1.32.
- Volume was 798.20K shares, 0.9x its 50-day average of 925.76K.
- Price is -16.4% vs its 50-day average ($1.53) and +18.5% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 31% of that range, 50.6% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — RNXT dips 2.9% to $1.33, a 1-month low, 4 down days in a row
- Closed at $1.33, -2.92% vs the prior close of $1.37. Day range $1.31–$1.37, opened at $1.33.
- Volume was 438.60K shares, 0.5x its 50-day average of 919.54K — lighter than usual.
- Price is -12.7% vs its 50-day average ($1.52) and +23.3% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 33% of that range, 48.6% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — RNXT dips 1.4% to $1.37, a 1-month low, 3 down days in a row
- Closed at $1.37, -1.44% vs the prior close of $1.39. Day range $1.27–$1.41, opened at $1.35.
- Volume was 589.80K shares, 0.6x its 50-day average of 912.14K.
- Price is -9.6% vs its 50-day average ($1.52) and +27.3% vs its 200-day average ($1.08).
- 52-week range $0.70–$2.59; today's close sits at 35% of that range, 47.1% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — RNXT slides 5.4% to $1.39, a 1-month low
- Closed at $1.39, -5.44% vs the prior close of $1.47. Day range $1.37–$1.57, opened at $1.51.
- Volume was 620.90K shares, 0.7x its 50-day average of 917.07K.
- Price is -7.7% vs its 50-day average ($1.51) and +29.4% vs its 200-day average ($1.07).
- 52-week range $0.70–$2.59; today's close sits at 36% of that range, 46.3% below the 52-week high.
Oct 5, 2026 — RNXT slides 7.0% to $1.47, a 1-month low
- Closed at $1.47, -6.96% vs the prior close of $1.58. Day range $1.43–$1.61, opened at $1.58.
- Volume was 618.00K shares, 0.7x its 50-day average of 907.68K.
- Price is -1.8% vs its 50-day average ($1.50) and +37.2% vs its 200-day average ($1.07).
- 52-week range $0.70–$2.59; today's close sits at 41% of that range, 43.2% below the 52-week high.
Oct 2, 2026 — RNXT rises 1.9% to $1.58
- Closed at $1.58, +1.94% vs the prior close of $1.55. Day range $1.55–$1.61, opened at $1.57.
- Volume was 269.40K shares, 0.3x its 50-day average of 903.75K — lighter than usual.
- Price is +6.4% vs its 50-day average ($1.49) and +47.9% vs its 200-day average ($1.07).
- 52-week range $0.70–$2.59; today's close sits at 47% of that range, 39.0% below the 52-week high.
RNXT latest news & SEC filings
Every SEC filing by or about RNXT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 15, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $909.00K (prior year $422.00K) (+115.4% vs Jun 30, 2025)
- Net income: -$2.91M (prior year -$2.90M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.06 (prior year -$0.08) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Exhibits / financial statements only (Item 9.01).
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Jun 30, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade RNXT
- Last results release: May 14, 2026 (8-K Item 2.02). Previous ones: Mar 30, 2026, Nov 13, 2025, Aug 14, 2025. Based on that rhythm, the next report is likely around Aug 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.32% (largest 8.0%). That is a volatile stock.
- Liquidity: about 527.81K shares (≈$601.70K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.14 vs a range of $0.70–$2.59 (23% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Mark Voll bought 25,000 shares on May 19, 2026.
- Latest filings: 8-K Aug 20, 2026; 10-Q Aug 13, 2026; 8-K Aug 12, 2026.
- Share count: 45.13M shares outstanding (Aug 7, 2026), +23.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
RNXT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.21 | 1.22 | 1.14 | 1.14 | 271.83K |
| Oct 15, 2026 | 1.11 | 1.22 | 1.11 | 1.19 | 328.60K |
| Oct 14, 2026 | 1.13 | 1.15 | 1.09 | 1.12 | 624.40K |
| Oct 13, 2026 | 1.24 | 1.27 | 1.13 | 1.15 | 942.40K |
| Oct 12, 2026 | 1.26 | 1.32 | 1.25 | 1.25 | 254.10K |
| Oct 9, 2026 | 1.32 | 1.35 | 1.25 | 1.28 | 798.20K |
| Oct 8, 2026 | 1.33 | 1.37 | 1.31 | 1.33 | 438.60K |
| Oct 7, 2026 | 1.35 | 1.41 | 1.27 | 1.37 | 589.80K |
| Oct 6, 2026 | 1.51 | 1.57 | 1.37 | 1.39 | 620.90K |
| Oct 5, 2026 | 1.58 | 1.61 | 1.43 | 1.47 | 618.00K |
| Oct 2, 2026 | 1.57 | 1.61 | 1.55 | 1.58 | 269.40K |
| Oct 1, 2026 | 1.57 | 1.59 | 1.50 | 1.55 | 404.00K |
| Sep 30, 2026 | 1.57 | 1.64 | 1.54 | 1.56 | 397.20K |
| Sep 29, 2026 | 1.57 | 1.59 | 1.51 | 1.57 | 370.00K |
| Sep 28, 2026 | 1.65 | 1.65 | 1.50 | 1.55 | 876.70K |
| Sep 25, 2026 | 1.69 | 1.73 | 1.64 | 1.66 | 490.60K |
| Sep 24, 2026 | 1.61 | 1.70 | 1.53 | 1.68 | 630.00K |
| Sep 23, 2026 | 1.70 | 1.80 | 1.60 | 1.63 | 765.00K |
| Sep 22, 2026 | 1.70 | 1.73 | 1.67 | 1.70 | 383.90K |
| Sep 21, 2026 | 1.69 | 1.74 | 1.63 | 1.67 | 482.50K |
About RenovoRx
RenovoRx (RNXT) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in MOUNTAIN VIEW, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1574094.
RNXT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ramtin Agah | Chief Medical Officer | Apr 7, 2026 |
| Shaun Bagai | Chief Executive Officer | Apr 7, 2026 |
| K. Angela Macfarlane | Director | Oct 2, 2025 |
| Laurence Marton | Director | Mar 24, 2026 |
| Una S Ryan | Director | Jun 24, 2026 |
| Robert J. Spiegel | Director | Oct 2, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ramtin Agah | Chief Medical Officer | Apr 7, 2026 |
| Shaun Bagai | Chief Executive Officer | Apr 7, 2026 |
| Leesa Gentry | Chief Clinical Officer | Apr 7, 2026 |
| Mark Voll | Chief Financial Officer | Sep 15, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 19, 2026 | Mark Voll | Buy | 25,000 | $0.79 |
| May 19, 2026 | Mark Voll | Buy | 25,000 | $0.79 |
| May 19, 2026 | Mark Voll | Buy | 25,000 | $0.79 |
| May 19, 2026 | Mark Voll | Buy | 25,000 | $0.79 |
| Mar 20, 2026 | Shaun Bagai | Buy | 24,300 | — |
| Mar 20, 2026 | Shaun Bagai | Buy | 24,300 | — |
| Mar 20, 2026 | Shaun Bagai | Buy | 24,300 | — |
| Mar 20, 2026 | Shaun Bagai | Buy | 24,300 | — |
| Mar 20, 2026 | Mark Voll | Buy | 97,200 | — |
| Mar 20, 2026 | Mark Voll | Buy | 97,200 | — |
| Mar 20, 2026 | Mark Voll | Buy | 97,200 | — |
| Mar 20, 2026 | Mark Voll | Buy | 97,200 | — |
| Mar 20, 2026 | Laurence Marton | Buy | 9,720 | — |
| Mar 20, 2026 | Laurence Marton | Buy | 9,720 | — |
| Mar 20, 2026 | Laurence Marton | Buy | 9,720 | — |
RNXT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.12M | $-11.17M | -0.32 | $-10.97M |
| Dec 31, 2024 | $43.00K | $-8.81M | -0.40 | $-9.12M |
| Dec 31, 2023 | — | $-10.23M | -0.99 | $-10.26M |
| Dec 31, 2022 | — | $-9.89M | -1.09 | $-8.81M |
| Dec 31, 2021 | — | $-6.32M | — | $-5.92M |
Latest balance sheet: total assets $11.47M, total liabilities $2.49M, cash $9.48M (as of Jun 30, 2026).
RNXT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 14, 2026 | 8-K Item 2.02 (results) | $0.86 |
| Mar 30, 2026 | 8-K Item 2.02 (results) | $1.07 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $0.97 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $1.24 |
| May 15, 2025 | 8-K Item 2.02 (results) | $1.11 |
| Apr 1, 2025 | 8-K Item 2.02 (results) | $0.96 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $1.09 |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 17, 2023 | 8-K Item 2.02 (results) | — |
| May 15, 2023 | 8-K Item 2.02 (results) | — |
| Mar 2, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RNXT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.